Low-level laser therapy for migraine

Authors

DOI:

https://doi.org/10.48208/HeadacheMed.2021.9

Keywords:

Migraine Disorders, Low-Level Light Therapy, Laser Therapy

Abstract

Correspondence

Downloads

Download data is not yet available.

References

Loeb LM, Amorim RP, Mazzacoratti MD, Scorza FA, Peres MF. Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison. Arq Neuropsiquiatr 2018;76(10):663-667 Doi: 10.1590/0004-282x20180109

Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008;28(5):484-495 Doi: 10.1111/j.1468-2982.2008.01555.x

Dodick DW, Reed ML, Fanning KM, Munjal S, Alam A, Buse DC et al. Predictors of allodynia in persons with migraine: results from the migraine in America symptoms and treatment (MAST) study. Cephalalgia 2019;39(7):873-882 Doi: 10.1177/0333102418825346

de Tommaso M, Brighina F, Delussi M. Effects of botulinum toxin A on allodynia in chronic migraine: An observational open-label two-year study. Eur Neurol 2019;81(1-2):37-46 Doi https://doi.org/10.1159/000499764

Chow RT, Johnson MI, Lopes Martins RA, Bjordal JM. Efficacy of lowlevel laser therapy in the management of neck pain: a systematic review and meta-analysis of randomized placebo or activetreatment controlled trials. Lancet 2009;374(9705):1897-1908 Doi: 10.1016/s0140-6736(09)61522-1

Pedro M, López-Pintor RM, Hoz-Aizpurua JL, Casañas E, Hernández DG. Efficacy of Low-Level Laser Therapy for the Therapeutic Management of Neuropathic Orofacial Pain: A Systematic Review. J Oral Facial Pain Headache 2020;34(1):13–30 Doi: 10.11607/ofph.2310

Downloads

Published

31/03/2021

How to Cite

1.
Siega MR de A, Oliveira WS. Low-level laser therapy for migraine. HM [Internet]. 2021 Mar. 31 [cited 2021 Sep. 26];:51. Available from: https://headachemedicine.com.br/index.php/hm/article/view/431

Issue

Section

Clinical Correspondence